Ontology highlight
ABSTRACT: Background
This study describes the conditions of use of ceftolozane/tazobactam (C/T) and associated outcomes in French hospital settings.Methods
This was a prospective, multicenter, French observational study. Patients who received at least 1 dose of C/T were included and followed up as per routine clinical practice, until stop of C/T.Results
A total of 260 patients were enrolled between October 2018 and December 2019 in 30 centers across France. Of these, 177 (68.0%) received C/T as per indication of usage following the results of the antibiogram (documented cases). Among documented patients, the mean age was 61.8 years, 73.4% were males, and 93.8% presented with multidrug-resistant (MDR) bacteria at inclusion. C/T was most frequently prescribed for pneumonia (48.
SUBMITTER: Timsit JF
PROVIDER: S-EPMC10883286 | biostudies-literature | 2024 Feb
REPOSITORIES: biostudies-literature